We don’t support this browser anymore.
This means our website may not look and work as you would expect. Read more about browsers and how to update them here.

Marble Point Loan Financing Ltd (MPLS) NPV (GBP)

Sell:46.00p Buy:56.00p 0 Change: No change
Market closed Prices as at close on 26 April 2024 Prices delayed by at least 15 minutes | Switch to live prices |
Ex-dividend
Sell:46.00p
Buy:56.00p
Change: No change
Market closed Prices as at close on 26 April 2024 Prices delayed by at least 15 minutes | Switch to live prices |
Ex-dividend
Sell:46.00p
Buy:56.00p
Change: No change
Market closed Prices as at close on 26 April 2024 Prices delayed by at least 15 minutes | Switch to live prices |
Ex-dividend
The selling price currently displayed is higher than the buying price. This can occur temporarily for a variety of reasons; shortly before the market opens, after the market closes or because of extraordinary price volatility during the trading day.

Objective

To generate stable current income and to grow NAV by earning a return on equity in excess of the amount distributed as dividends through exposure to a diversified portfolio of US Dollar denominated, broadly syndicated floating rate senior secured corporate loans.
Security Weight
Mp Clom 68.98%
Clo Equity 55.14%
Common Stock 0.97%
Loans 0.17%

Top 10 sectors currently unavailable.

Top 10 countries currently unavailable.

Fee Structure

An investment management fee payable quarterly in arrears, in an amount equal to 0.40% p.a. of the consolidated TA of the company. No performance fees are charged. The Investment Manager may resign its role upon 60 days written notice.

Dividend Policy

The Company targets: (i) an annualised total return in the low-to-mid teens over the long-term; and (ii) a dividend of 2% per quarter (equating to 8% p.a.) based on the Issue Price, with the Target Dividend increasing to 2.50% per quarter (equating to 10% p.a.) of the Issue Price in the second year following the Initial Admission Date.

ASSET SPLIT

Total number of holdings: 8.

Trust Manager

Not currently available for this investment trust.

Manager Bio

Not currently available for this investment trust.

Board Of Directors

Robert BrownChairman, John Falla, Sandra Platts, Paul Greenberg, Thomas Shandell

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Objective, holding data, trust manager and bio information, dividend policy, asset split and fee structure are provided by Morningstar.

The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.

Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.